Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Adult and Adolescent Hemophilia Patients Treated With Marstacimab: a Patient Experience Registry

NCT06992076 is registered in ClinicalTrials.gov with Institute of Hematology & Blood Diseases Hospital, China as lead sponsor.

NCT NCT06992076
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06992076 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Adult and Adolescent Hemophilia Patients Treated With Marstacimab: a Patient Experience Registry
Lead sponsor
Institute of Hematology & Blood Diseases Hospital, China
Phase
Observational
Overall status
Recruiting
Start date
February 15, 2026
Completion date
December 31, 2028
Enrollment
100 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hemophilia